Clinical Research Directory
Browse clinical research sites, groups, and studies.
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Sponsor: Fudan University
Summary
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1012. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for ground glass-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are: * The 5-year disease-free survival of patients having ground glass-dominant invasive lung cancer with size of 2-3cm; * The post-operative lung function tests after receiving segmentectomy. Participants will receive segmentectomy as the surgical procedure.
Official title: Segmentectomy for Ground Glass-dominant Invasive Lung Cancer With Size of 2-3cm: a Single-arm, Multi-center, Phase III Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
307
Start Date
2023-02-15
Completion Date
2029-12-31
Last Updated
2024-06-03
Healthy Volunteers
No
Conditions
Interventions
Segmentectomy
The lungs are divided into multiple lobes. A segmentectomy involves the removal of part of one of the lobes of the lung to entirely remove a cancerous tumor. segmentectomy can preserve more normal functional lung tissues.
Locations (1)
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China